Anna Azvolinsky

976 total citations
55 papers, 781 citations indexed

About

Anna Azvolinsky is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Azvolinsky has authored 55 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Azvolinsky's work include Cancer, Lipids, and Metabolism (5 papers), CRISPR and Genetic Engineering (4 papers) and DNA Repair Mechanisms (3 papers). Anna Azvolinsky is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), CRISPR and Genetic Engineering (4 papers) and DNA Repair Mechanisms (3 papers). Anna Azvolinsky collaborates with scholars based in United States, Italy and Canada. Anna Azvolinsky's co-authors include Virginia A. Zakian, Paul G. Giresi, Jason D. Lieb, Stephen Dunaway, Jorge Z. Torres, Jessica B. Bessler, Jinhong Chang, Gloria Moraleda, John M. Taylor and Severin O. Gudima and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Genes & Development.

In The Last Decade

Anna Azvolinsky

52 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Azvolinsky United States	10	584	114	110	96	96	55	781
Shwu‐Yuan Wu United States	11	739 1.3×	165 1.4×	160 1.5×	201 2.1×	54 0.6×	16	958
Mark J. Dycaico United States	11	546 0.9×	49 0.4×	187 1.7×	108 1.1×	91 0.9×	15	733
Einat Almon Israel	11	298 0.5×	53 0.5×	81 0.7×	137 1.4×	103 1.1×	23	527
T. Bunte Germany	14	293 0.5×	61 0.5×	127 1.2×	87 0.9×	23 0.2×	25	531
Koji Kitada Japan	14	698 1.2×	52 0.5×	34 0.3×	286 3.0×	172 1.8×	46	1.1k
K Q Hu United States	8	298 0.5×	233 2.0×	37 0.3×	34 0.4×	19 0.2×	10	539
Mathieu Lajoie Canada	14	399 0.7×	138 1.2×	107 1.0×	158 1.6×	46 0.5×	24	712
Florence Le Roy France	15	430 0.7×	55 0.5×	46 0.4×	125 1.3×	12 0.1×	19	630
Dasong Hua China	9	379 0.6×	113 1.0×	27 0.2×	136 1.4×	21 0.2×	10	588
Rubén Bonilla Guerrero United States	7	223 0.4×	197 1.7×	48 0.4×	54 0.6×	9 0.1×	15	506

Countries citing papers authored by Anna Azvolinsky

Since Specialization

Citations

This map shows the geographic impact of Anna Azvolinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Azvolinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Azvolinsky more than expected).

Fields of papers citing papers by Anna Azvolinsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Azvolinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Azvolinsky. The network helps show where Anna Azvolinsky may publish in the future.

Co-authorship network of co-authors of Anna Azvolinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Azvolinsky. A scholar is included among the top collaborators of Anna Azvolinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Azvolinsky. Anna Azvolinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Azvolinsky, Anna. (2019). Molecular scissors cut in on stem cells. Nature Medicine. 25(6). 864–866. 1 indexed citations

Azvolinsky, Anna. (2017). Statins for Cancer: Still Uncertain. JNCI Journal of the National Cancer Institute. 109(5). 1 indexed citations

Azvolinsky, Anna, Laura DeFrancesco, Emily Waltz, & Sarah Webb. (2016). 20 years of Nature Biotechnology research tools. Nature Biotechnology. 34(3). 256–261. 2 indexed citations

Azvolinsky, Anna. (2016). Unraveling How Obesity Fuels Cancer. JNCI Journal of the National Cancer Institute. 108(4). djw116–djw116. 3 indexed citations

Azvolinsky, Anna, Charles W. Schmidt, Emily Waltz, & Sarah Webb. (2016). 20 years of Nature Biotechnology biomedical research. Nature Biotechnology. 34(3). 262–266. 6 indexed citations

Azvolinsky, Anna. (2015). Colorectal Cancer: To Stack or Sequence Therapy?. JNCI Journal of the National Cancer Institute. 107(5). djv138–djv138. 18 indexed citations

Azvolinsky, Anna. (2014). Mystery around drug adherence still plagues medical literature. Nature Medicine. 20(5). 455–455. 1 indexed citations

Azvolinsky, Anna. (2014). New HPV Vaccine Could Prevent 90% of Cervical Cancers.

Azvolinsky, Anna. (2013). ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed. 1 indexed citations

10.

Azvolinsky, Anna. (2013). Diagnostic lens turns to difficult-to-detect ovarian cancer. Nature Medicine. 19(2). 117–117. 1 indexed citations

11.

Azvolinsky, Anna. (2013). Supreme Court Ruling Broadens BRCA Testing Options. JNCI Journal of the National Cancer Institute. 105(22). 1671–1672. 13 indexed citations

12.

Azvolinsky, Anna. (2013). Cancer Vaccines: Always a Bridesmaid, Never a Bride?. JNCI Journal of the National Cancer Institute. 105(4). 248–249. 5 indexed citations

13.

Azvolinsky, Anna. (2012). PARP Inhibitors: Targeting the Right Patients. JNCI Journal of the National Cancer Institute. 104(24). 1851–1852. 1 indexed citations

14.

Azvolinsky, Anna. (2012). Preserving Fertility in Cancer Patients. JNCI Journal of the National Cancer Institute. 104(10). 724–725. 3 indexed citations

15.

Azvolinsky, Anna. (2012). Companies hope for rare win with cancer stem cell therapies. Nature Medicine. 18(4). 474–474. 2 indexed citations

16.

Azvolinsky, Anna. (2011). Categorization of triple-negative breast cancer patients will help in targeted therapy selection.. PubMed. 25(9). 849–849. 1 indexed citations

17.

Fachinetti, Daniele, Rodrigo Bermejo, Andrea Cocito, et al.. (2010). Replication Termination at Eukaryotic Chromosomes Is Mediated by Top2 and Occurs at Genomic Loci Containing Pausing Elements. Molecular Cell. 39(4). 595–605. 118 indexed citations

18.

Azvolinsky, Anna, Paul G. Giresi, Jason D. Lieb, & Virginia A. Zakian. (2009). Highly Transcribed RNA Polymerase II Genes Are Impediments to Replication Fork Progression in Saccharomyces cerevisiae. Molecular Cell. 34(6). 722–734. 233 indexed citations

19.

Cozma, Dragoș, Duonan Yu, Anna Azvolinsky, et al.. (2007). B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. Journal of Clinical Investigation. 117(9). 2602–2610. 35 indexed citations

20.

Azvolinsky, Anna, Stephen Dunaway, Jorge Z. Torres, Jessica B. Bessler, & Virginia A. Zakian. (2006). The S. cerevisiae Rrm3p DNA helicase moves with the replication fork and affects replication of all yeast chromosomes. Genes & Development. 20(22). 3104–3116. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact